Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma cells and preclinical models

Medulloblastoma is an aggressive pediatric brain tumor that can be driven by misactivation of the Hedgehog (HH) pathway. CDK6 is a critical effector of oncogenic HH signaling, but attempts to target the HH pathway in medulloblastoma have been encumbered by resistance to single-agent molecular therap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Daggubati, Vikas, Hochstelter, Jordan, Bommireddy, Anirudh, Choudhury, Abrar, Krup, Alexis Leigh, Kaur, Pervinder, Tong, Pakteema, Li, Amy, Xu, Libin, Reiter, Jeremy F., Raleigh, David R.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2021
Matèries:
Concise Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954583/
https://ncbi.nlm.nih.gov/pubmed/33476305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI141171
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars